Delivery Order SPE2DB24D2106-SPE2DB24FATYC
Award Date
3/21/24
Potential Completion Date
3/22/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,082.72 contract is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on July 16, 2024. The $2,104.02 fixed-price contract is for the delivery of an Advair HFA 230-21 MCG inhaler product. The order is part of the DLA's Medical Supply Chain division and is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,952.07 order is for 4,565,007,305 units of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a prescription medication, with a ceiling value of $8,749.44 and a completion date of April 24, 2024. The contract is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,715.40, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 8GM, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,562.04 for the supply of pharmaceutical products, including Advair HFA 115-21 MCG inhalers. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is part of the SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, with a ceiling value of $1,242.48 and a completion date of May 21, 2024. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to $499,999,999, which allows the DLA to issue...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of Advair HFA 115-21 MCG Inhaler 12GM. The $4,157.10 contract has a completion date of June 6, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $18,376.12 award is for the supply of the medication ADVAIR HFA 115-21 MCG INHALER 12GM. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA through the SPE2DB program, which allows the DLA to place delivery orders for a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,385.11 contract is for the delivery of 4565520224 ADVAIR HFA 230-21 MCG INHALER 12GM, with a completion date of August 21, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to the Department...